Назол

Quick links to important sections

Назол

Selected form

Method of action: Alpha-Adrenomimetic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Назол

Quick Facts

Property Description
Active ingredient Oxymetazoline hydrochloride
Form Topical solution (Nasal spray or drops)
Pharmacological class Alpha-adrenergic agonist, Sympathomimetic
General use Symptomatic relief of nasal congestion
Origin Synthetic Imidazoline derivative

What Type of Medicine is Назол and What is its Classification?

The medicine Назол is a direct-acting sympathomimetic amine classified pharmacologically as an alpha-adrenergic agonist, intended for the localized symptomatic relief of nasal congestion. Its core component is the active ingredient, Oxymetazoline hydrochloride, a potent, synthetic Imidazoline derivative. This classification reflects its role in directly affecting the vascular tissues in the nose. Unlike some older agents, Oxymetazoline provides sustained local vasoconstriction, which is a key differentiator among topical decongestants.

Composition and Physical Form of Назол

Назол is supplied as a topical solution designed exclusively for nasal administration, typically available as a nasal spray or nasal drops. This formulation ensures targeted relief by delivering the Oxymetazoline hydrochloride directly to the nasal mucosa. The solution is formulated with the active substance dissolved in an appropriate base, providing a straightforward means of application directly to the swollen nasal lining. The product is frequently positioned for use by the general public seeking rapid, non-prescription symptomatic relief.

What is the General Therapeutic Purpose of Назол?

The general therapeutic purpose of this medicine is to promote the decongestion of nasal passages to ease breathing difficulty. By initiating localized action on the blood vessels, the Oxymetazoline induces vasoconstriction, causing the inflamed and engorged mucous membranes to shrink. This action effectively reduces the excess fluid and engorgement that causes obstruction, providing symptomatic relief by temporarily restoring the patency of the nasal airways.

Regulatory References

  1. MedlinePlus - Nasal Decongestants

What side effects are possible with Назол?

Possible side effects and safety information

The safety profile for Oxymetazoline hydrochloride is primarily defined by local adverse reactions and specific systemic considerations related to its classification as an alpha-adrenergic agonist. Regulatory documents categorize possible adverse events by the body systems affected.


Officially Documented Adverse Reactions

Adverse reactions listed in official regulatory labeling chiefly involve the Respiratory, Thoracic, and Mediastinal Disorders System-Organ Class. These common, temporary local effects at the application site include burning, stinging, nasal dryness, or sneezing.

Less frequently, due to potential systemic absorption, effects classified under the Nervous System Disorders (such as dizziness, headache, or insomnia) and Cardiac Disorders (such as changes in heart rate like tachycardia or bradycardia) may occur

. These systemic reactions emphasize the need for caution in patients with pre-existing conditions.


Safety Patterns and Restrictions

A critical safety pattern documented in labeling is the risk of rebound nasal congestion (Rhinitis medicamentosa). This paradoxical worsening of congestion is explicitly associated with frequent or prolonged use beyond the recommended duration.

Due to the potential for systemic effects, official labeling advises caution for patients with cardiovascular conditions (e.g., high blood pressure or heart disease), thyroid disease, or diabetes. Furthermore, restrictions are noted for concomitant use with certain medications, such as Monoamine Oxidase Inhibitors (MAOIs), where use requires particular safety attention. The label also notes that accidental oral ingestion, particularly in children, carries a risk of severe systemic toxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose with this product, particularly due to accidental oral ingestion or excessive use, poses a significant risk of systemic toxicity, especially in children. Official regulatory information states that severe outcomes can be life-threatening.

Documented Overdose Symptoms

The clinical manifestations of an overdose primarily affect the Central Nervous System (CNS) and the Cardiovascular System. Documented presentations include:

  • CNS Effects: Nausea, vomiting, fever, convulsions, and, in severe cases, profound CNS depression, leading to collapse and coma.
  • Cardiovascular Effects: Tachycardia (fast heart rate), cardiac arrhythmias (irregular heartbeat), and hypertension (high blood pressure). Serious overdose may also result in shock and pulmonary edema.

Emergency Action

Immediate medical attention is required in all cases of suspected overdose.

Even if initial symptoms appear mild or are not yet present, professional medical help must be sought immediately. This is due to the potential for severe, rapidly developing systemic effects, especially following accidental ingestion by a child.

The regulatory-based instructions for overdose management typically involve symptomatic treatment under medical supervision. Procedural instructions for life support, such as the use of activated charcoal, gastric lavage (if medically indicated), and artificial respiration, are explicitly stated in official prescribing information for managing the most severe cases of toxicity.

Therapeutic Uses of Назол

The medicine is relevant for easing certain distressing symptoms. The active ingredient is commonly used across conditions involving episodic or fluctuating manifestations.


Easing Nasal and Sinus Discomfort

This therapeutic domain is relevant in contexts marked by increased discomfort or tension, relating to symptoms of physical discomfort. These symptoms include stuffy nose, nasal congestion, and sinus pressure. Nazol may assist with easing the overall symptom burden during periods of heightened symptoms. It is relevant for managing symptoms associated with conditions where symptoms may intensify temporarily, such as those related to the common cold and upper respiratory allergies.

“Applied in clinical settings that involve acute or unstable symptom patterns.”


Supporting Comfort and Functional Stability

Nazol is commonly used in contexts where symptoms that interfere with daily functioning appear suddenly. It is often used during phases when symptoms become more noticeable. The medicine may help patients cope more steadily with symptom fluctuations during acute episodes, supporting general well-being during symptomatic phases.


Quick Fact: The medicine is used for managing Nasal Congestion

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility Rules for Назол (Oxymetazoline)

Official regulatory documents define strict limitations for the use of Oxymetazoline hydrochloride, the active ingredient in Назол, based on age, pre-existing conditions, and physiological state.


Population Eligibility Summary

Category Official Regulatory Status/Wording
Populations Allowed Adults and children 6 years of age and older (for standard 0.05% concentration).
Use Not Recommended Children under 6 years of age must consult a doctor. Use in children under 2 years is generally not recommended or not established.
Contraindicated Patients with known hypersensitivity to the ingredient or any component, or those who have recently used a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.

Conditional Use Restrictions

Regulatory labeling advises individuals with certain chronic conditions to ask a doctor before use, thereby restricting self-medication. These conditions include heart disease, high blood pressure (hypertension), diabetes, thyroid disease, and difficulty urinating due to an enlarged prostate gland. Individuals with glaucoma or those who have had specific nasal surgeries are also subject to restriction or contraindication.


Pregnancy and Lactation

For pregnant or breastfeeding individuals, regulatory documents mandate they ask a health professional before use, as the safety of the medicine in these populations is not fully established.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents describe interaction patterns primarily involving pharmacodynamic potentiation and local administration constraints for Oxymetazoline (the active ingredient in Назол).

Classification Detail Official Regulatory Statement
Medicinal Product Categories Monoamine Oxidase Inhibitors (MAOIs), Tricyclic Antidepressants (TCAs), Nonselective Beta-Adrenergic Antagonists (Beta-Blockers), Other Sympathomimetic Amines, Other Intranasal Products
Interaction-Related Restrictions Contraindicated with MAOIs, and restricted for up to two weeks following the cessation of MAOI therapy.

Co-administration with MAOIs (such as Isocarboxazid, Phenelzine, or Tranylcypromine) is officially documented as presenting a risk of severe hypertension (hypertensive crisis).

Similarly, co-use with TCAs and nonselective beta-blockers may cause potentiation of pressor effects, which is officially stated to increase the risk of hypertension or arrhythmias.

Administration Constraints

The medicine may affect the local absorption of other products administered into the nose. The official label includes a timing-based rule for co-administration with intranasal Zavegepant, requiring that the decongestant be administered at least 1 hour after Zavegepant to manage the documented decrease in the other product's effect or level.

No specific interaction outcomes are explicitly documented in primary regulatory labels concerning food, alcohol, or herbal products.

Mechanism of Action

How Назол Works


Direct Modulation of Nasal Vascular Tone

This domain covers the drug's action as a direct-acting sympathomimetic amine that primarily targets post-synaptic Alpha-1 (alpha1) and Alpha-2 (alpha2) adrenoceptors on the smooth muscle of nasal blood vessels. By initiating rapid, targeted vasoconstriction, the mechanism controls the microcirculation dynamics and limits the local blood supply to the nasal microvasculature.


The Mechanistic Cascade: From Receptor to Vascular Contraction

The mechanism operates through a classic G-Protein Coupled Receptor (GPCR) signaling cascade, where receptor activation mobilizes intracellular calcium ( Ca^2+) to contract the vascular muscle cells. This forceful contraction reduces the vessel diameter, leading directly to the physical volume reduction of the nasal mucosa and a reduction in local tissue fluid.


Constraint: Mechanisms of Rebound and Tachyphylaxis

This domain addresses the inherent limitations of the vasoconstrictive mechanism, including tachyphylaxis (diminished response) caused by receptor down-regulation following prolonged exposure. This constraint can lead to a physiological dependency and a paradoxical mechanism reversal upon withdrawal toward reactive hyperemia.

Dosage and Administration Information

The use of the medicine is based on a standardized protocol for administration via the intranasal route. The medicine is supplied as a topical solution in two primary concentrations: 0.05% and 0.025% Oxymetazoline Hydrochloride.

Standard Labeled Use and Frequency

Administration is structured around a mandatory 10 to 12-hour interval between doses. The maximum limit for daily usage is strictly two doses in any 24-hour period.

Population Strength Dose per Nostril
Adults (≥ 12) 0.05% 2 or 3 sprays/drops
Children 6 to 12 0.05% 2 or 3 sprays/drops (with adult supervision)
Children 2 to 6 0.025% 2 or 3 sprays/drops (consultation required)

Course Duration and Procedural Conditions

The application is classified as short-term use only. The protocol stipulates that the medicine must not be used for more than 3 consecutive days. This time restriction is an essential constraint of the standard usage protocol.

For correct administration, nasal pump dispensers typically require priming before the initial use. To maintain hygiene, the container is not intended to be shared, and the nozzle should be wiped clean after each application. For children under the age of two, consultation with a healthcare professional is required before use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nasal Congestion Relief

This section will organize and summarize the available clinical research, primarily focusing on controlled trials and observational settings, that have investigated the use of this nasal spray in research scenarios involving conditions associated with acute or disruptive episodes. The information below describes what researchers have studied, what patterns the data show so far, and what aspects remains uncertain.


Evidence for Temporary Relief of Nasal Congestion from Colds and Allergies

Research exploring short-term symptom changes has mainly focused on adults experiencing conditions characterized by fluctuating or episodic manifestations, such as common cold and allergy-related nasal congestion. These studies have evaluated the nasal spray over brief observation periods, often lasting only a few days. Researchers measured outcomes related to physical discomfort, specifically changes in nasal passage openness and patient-reported outcomes describing perceived discomfort.

The studies report how symptoms evolved in the observed populations during the defined time intervals. Findings describe patterns observed in the studies related to changes measured in outcomes linked to inflammatory or irritative states and changes measured in the severity of nasal stuffiness. Research highlights changes measured during the short study period, consistent with trials assessing short-term or episodic symptom patterns.

However, the existing research provides limited insight into the durability of these short-term changes. The results apply only to the populations studied under the specific conditions of the trial. Certainty remains low regarding the consistency of these patterns across highly varied allergy triggers or cold types. Follow-up durations were limited, meaning the evidence contributes to understanding acute symptom patterns but not long-term outcomes.


Long-term Studies and Follow-up Data

Research exploring long-term outcomes for this nasal spray is extremely limited. The vast majority of studies have been designed for short-term observation only. Long-term effects are not fully established.

Studies observing responses over defined time intervals do not provide data regarding knowledge gaps related to outcomes of continuous use over extended periods. This lack of extended-duration data means that evidence contributes to understanding acute symptom patterns, but long-term effects are not fully established, including data related to continuous use over extended periods.


What Is Still Uncertain About This Nasal Spray

The existing evidence base, which reports data related to short-term changes, contains several research limitation frames. Specifically, follow-up durations were limited across nearly all studies, meaning the consequences of repeated or prolonged use are not well characterized. Comparative evidence is lacking against other treatment modalities for acute nasal congestion. Additionally, evidence quality varies across studies, and some sample sizes were modest, which affects the generalizability of the findings.

Frequently Asked Questions (FAQ)

Common questions about Назол (FAQ)


Q: How quickly can I expect to notice the effects of Назол?

The active ingredient is described in regulatory standards as having a rapid onset of action. Official regulatory standards permit the description of 'fast relief,' as the drug is known to relieve congestion and improve airflow within minutes of application.

Q: What is the typical duration of effect for one use of Назол?

Official regulatory standards permit references to '12 hour relief' for the active ingredient in this medicine. Studies summarized in regulatory documents indicate that the temporary relief of nasal congestion may last for up to 12 hours following a single dose. This duration is consistent with the mandatory minimum interval between uses as outlined in the administration protocol.

Q: Is Назол the same as other nasal sprays I see advertised?

Назол contains the active ingredient Oxymetazoline hydrochloride, which is classified as a sympathomimetic decongestant. Its purpose is to shrink swollen nasal membranes by causing vasoconstriction, or the narrowing of blood vessels. This mechanism is different from how non-drug products like saline sprays or prescription steroid sprays work.

Q: What does 'rebound congestion' mean when related to nasal sprays?

Rebound congestion, also known as Rhinitis medicamentosa, is a safety constraint noted in official warnings. It describes a situation where the initial congestion symptoms recur or worsen paradoxically. This reaction is explicitly associated with using the nasal spray too frequently or for longer than the recommended short duration.

Q: Is it possible to become dependent on Назол?

The active substance itself is not classified as a controlled drug and is not known to be chemically habit-forming. However, official warnings describe the risk of developing rebound congestion (Rhinitis medicamentosa) from overuse. This condition involves a physiological adaptation where the body may rely on the drug’s effect to prevent the recurrence of congestion.

Q: What should I do if the spray seems ineffective after a few days?

Official warnings state that the product is intended for short-term use and must not be used for more than three consecutive days. If nasal congestion persists or if the spray seems ineffective after this period, regulatory guidance advises seeking advice from a doctor or pharmacist.

Q: Does the medicine go into the bloodstream after using the nasal spray?

Pharmacokinetic studies summarized in regulatory documents indicate that the medicine is absorbed systemically following nasal administration. This means that a small amount of the drug does enter the bloodstream. Measurable concentrations are typically reached within the first 5 to 10 minutes after application.

Q: What are the signs of using too much of the active ingredient in a nasal spray?

Serious systemic effects are rare but can occur, especially if an excessive amount of the medicine is accidentally swallowed. Signs of potential over-absorption are documented to include changes in heart rate, such as palpitations or tachycardia, or elevated blood pressure (hypertension).

Q: What happens if I accidentally swallow some of the spray?

Accidental oral ingestion, particularly by children, is a documented safety concern that carries a risk of severe systemic toxicity. Serious effects, such as changes to heart rate and blood pressure, may be more likely if an excessive amount is swallowed.

Q: Does using Назол affect my ability to drive or operate machinery?

Official product information lists potential systemic side effects, including nervous system disorders such as dizziness and headache. If a person experiences these or similar nervous system effects, official information notes that their capacity to drive or safely operate machinery may be affected.

Q: Are eye irritation or changes in vision listed as potential side effects?

Warnings associated with the drug's pharmacological class note that if individuals experience blurred vision, they should seek medical attention. This caution is noted in official labeling due to the potential for the medicine to cause systemic effects.

Q: Are there any known interactions between Назол and blood pressure medicine?

As a medication belonging to the alpha-adrenergic agonist class, the drug's mechanism may potentially affect blood pressure. Official information notes that caution applies when the product is used by patients who are receiving certain medications for high blood pressure or heart conditions. This includes specific drugs such as beta-blockers or cardiac glycosides, due to the potential for additive effects.

Q: Is it described as safe to use other cold medicines with Назол?

Regulatory warnings note that co-administration of this medicine with other sympathomimetic agents is restricted. This class of ingredients, which includes substances like phenylephrine or pseudoephedrine, is often found in other cold and cough medicines. Combining them carries a risk of potential additive effects.

Q: Can I use Назол if I am taking over-the-counter pain relievers?

General interaction checks for the active ingredient with common over-the-counter pain relievers, such as acetaminophen, have not shown known interactions. However, official guidance emphasizes the need to review all drug combinations.

Q: Does the product contain any common allergens like gluten or lactose?

Official drug listings provide a list of inactive ingredients used in the product's formulation, which typically includes substances such as benzalkonium chloride and propylene glycol. Official drug labeling contains the complete ingredient list, which can be reviewed against known personal allergens.

Q: What is the current regulatory status of Назол in major health regions?

In the United States and other major health regions, products containing Oxymetazoline hydrochloride nasal spray are generally categorized as Over-the-Counter (OTC) human drug products. This classification defines the product's availability to the general public for self-medication of symptoms.

Q: Is the active substance in Назол a controlled substance?

Official drug classifications confirm that the active substance, Oxymetazoline hydrochloride, is not categorized as a controlled drug by US regulatory bodies. This status means it is not subject to the specific regulations governing prescription and usage of controlled substances.

How should Назол be stored and disposed of?

How to Store and Dispose of Nazol (Oxymetazoline Hydrochloride)

The official storage conditions for Nazol are defined to ensure product stability and safety. The medication must be kept at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F), with protection from environmental extremes.

Storage Requirements

  • Temperature: Do not allow the product to freeze, and protect it from excess heat, light, and moisture.
  • Container: The container must be kept tightly closed in its original carton, and the product should not be used if the tamper-evident seal is broken or missing.
  • Child Safety: It is mandatory to keep Nazol out of the sight and reach of children; if swallowed, contact a Poison Control Center immediately.

Disposal Instructions

Regulatory guidance advises against flushing unneeded medication down the toilet. Disposal should be done through an authorized medicine take-back program when available, or by methods that prevent consumption by people or pets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Назол found in:

A-Z Index: